Kiniksa Pharmaceuticals
KNSA
#4668
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
59.49%
Change (1 year)
Categories
Revenue for Kiniksa Pharmaceuticals (KNSA)
Revenue in 2023 (TTM): $0.27 B
According to Kiniksa Pharmaceuticals
's latest financial reports the company's current revenue (TTM
) is $0.27 B.
In 2022 the company made a revenue of $0.22 B an increase over the years 2021 revenue that were of $38.54 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kiniksa Pharmaceuticals from 2017 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.27 B | 22.74% |
| 2022 | $0.22 B | 471.24% |
| 2021 | $38.54 M | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |